We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$54B
AUM Growth
-$5.26B
Cap. Flow
-$7.55B
Cap. Flow %
-13.98%
Top 10 Hldgs %
49.89%
Holding
190
New
14
Increased
43
Reduced
46
Closed
38

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$849M
2
BABA icon
Alibaba
BABA
+$551M
3
DLO icon
dLocal
DLO
+$178M
4
BIDU icon
Baidu
BIDU
+$156M
5
NTES icon
NetEase
NTES
+$155M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$311M
2
ATVI
Activision Blizzard
ATVI
+$246M
3
SNPS icon
Synopsys
SNPS
+$242M
4
XLRN
Acceleron Pharma
XLRN
+$214M
5
TWLO icon
Twilio
TWLO
+$214M

Sector Composition

Rank Sector Weight
1 Technology 26.2%
2 Consumer Discretionary 10.52%
3 Financials 4.99%
4 Communication Services 4.7%
5 Real Estate 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMT icon
151
4D Molecular Therapeutics
FDMT
$562M
-602,225
Closed -$16.2M
GIS icon
152
CALL
General Mills
GIS
$19.7B
-2,000,000
Closed -$120M
HPQ icon
153
CALL
HP
HPQ
$27.5B
-2,000,000
Closed -$54.7M
JD icon
154
CALL
JD.com
JD
$44.5B
-2,800,000
Closed -$202M
LYFT icon
155
CALL
Lyft
LYFT
$6.63B
-1,000,000
Closed -$53.6M
MRSN
156
DELISTED
Mersana Therapeutics
MRSN
-71,994
Closed -$17M
MTCH icon
157
Match Group
MTCH
$8.55B
-338,416
Closed -$53.1M
NFLX icon
158
Netflix
NFLX
$309B
-5,088,450
Closed -$311M
RLMD icon
159
Relmada Therapeutics
RLMD
$527M
-100,000
Closed -$2.62M
RSKD icon
160
Riskified
RSKD
$716M
-398,385
Closed -$9.09M
RXRX icon
161
Recursion Pharmaceuticals
RXRX
$1.73B
-548,455
Closed -$12.6M
SNAP icon
162
CALL
Snap
SNAP
$9.01B
-3,000,000
Closed -$222M
SNOW icon
163
Snowflake
SNOW
$115B
-3,366
Closed -$1.02M
U icon
164
Unity
U
$18.9B
-27,000
Closed -$3.41M
VTEX icon
165
VTEX
VTEX
$713M
-498,621
Closed -$10.3M
ZG icon
166
Zillow
ZG
$7.63B
-80,000
Closed -$7.09M
DAY
167
DELISTED
Dayforce
DAY
-719,053
Closed -$81M
MORF
168
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-391,452
Closed -$22.2M
DCPH
169
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-396,977
Closed -$13.5M
MIMO
170
DELISTED
Airspan Networks Holdings Inc
MIMO
-2,000,000
Closed -$13.4M
TPTX
171
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-626,046
Closed -$41.6M
ARNA
172
DELISTED
Arena Pharmaceuticals Inc
ARNA
-1,741,531
Closed -$104M
XLRN
173
DELISTED
Acceleron Pharma
XLRN
-1,245,412
Closed -$214M

Similar funds

Alkeon Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Alkeon Capital Management held 190 positions worth $54B, down 8.9% from $59.2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Alkeon Capital Management withdrew a net $7.55B in Q4 2021, closing 38 positions and reducing 46 holdings. Its most notable exit was Netflix, an estimated $311M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Alkeon Capital Management opened a new position in Qualcomm worth $970M.

  • Alkeon Capital Management's largest Q4 2021 buy was Qualcomm: 5,305,000 shares worth $970M.
  • Alkeon Capital Management added most to Alibaba in Q4 2021, an estimated $551M increase.
  • Alkeon Capital Management's biggest Q4 2021 reduction was Activision Blizzard, cutting an estimated $246M.
  • Alkeon Capital Management fully exited Netflix in Q4 2021, selling an estimated $311M.
  • Alkeon Capital Management's ten largest holdings make up 50% of its $54B portfolio in Q4 2021.
  • Alkeon Capital Management opened 14 new positions and closed 38 in Q4 2021.
  • Alkeon Capital Management's portfolio value fell 8.9% quarter-over-quarter to $54B.

Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.